Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2014

Dec 8, 2014

35119_dirs_2014-12-08_8464e874-c916-4ab8-a90c-22dbf381e20d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2014-12-04

Reporting Person: SCHABER CHRISTOPHER J (Director, Chairman, CEO and President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-04 Option (Right to Buy) $1.50 A 100000 Acquired 2024-12-03 Common Stock (100000) Direct

Footnotes

F1: The stock option vested immediately as to 25,000 shares and vests as to the remainder at a rate of 6,250 shares on each three (3) month anniversary of December 4, 2014.